Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1

Interventions

relacorilant 5somapacitan 1semaglutide 1saxagliptin 1pembrolizumab 1empagliflozin 1dapagliflozin 1Rosiglitazone 1Metformin 1Dipeptidyl-Peptidase IV Inhibitors 1ASP3662 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Diabetes Mellitus, Type 2 × semaglutide × Clear all
NCT04572165 2024-01-02

Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data

Novo Nordisk A/S

Unknown
600,000 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡